Tango Therapeutics Inc Capital Reinvestment Ratio

Latest as of September 2020: 0.00x

Tango Therapeutics Inc capital reinvestment ratio. Tango Therapeutics Inc (TNGX) has a Capital Reinvestment Ratio of 0.00x as of September 2020, meaning it reinvests 0% of its operating cash flow ($111.26 Million) in capital expenditures ($132.00K). See Tango Therapeutics Inc (TNGX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$111.26 Million

USD

Capital Expenditures

$132.00K

USD

Data as of

Sep 2020

Most recent filing

Capital Reinvestment Ratio of Tango Therapeutics Inc (2020–2020)

Capital reinvestment ratio of Tango Therapeutics Inc from 2020 to 2020. This chart tracks Tango Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. See how financially flexible is Tango Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.

Tango Therapeutics Inc Capital Reinvestment Ratio by Year (2020–2020)

Tango Therapeutics Inc capital reinvestment ratio by year from 2020 to 2020. For the full cash flow conversion analysis, see cash efficiency ratio of Tango Therapeutics Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2020	0.02x	$70.07 Million	$1.11 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow